These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17332006)

  • 1. Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection.
    Laoi BN; Herra C; Norris S; Crowley B
    J Antimicrob Chemother; 2007 Apr; 59(4):807-9. PubMed ID: 17332006
    [No Abstract]   [Full Text] [Related]  

  • 2. Does pre-treatment with lamivudine prime for adefovir resistance of hepatitis B virus infection?
    Sirma H; Funk A; Gerlich W; Schildgen O
    J Antimicrob Chemother; 2007 Aug; 60(2):448-9. PubMed ID: 17561492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province].
    Hu AR; Jiang SW; Li L; Ding SX; Hu YR; Liang XY
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1878-81. PubMed ID: 23134956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of genotypic resistance to adefovir in chronic HBV in the Republic of Ireland.
    Laoi BN; Herra C; Norris S; Crowley B
    J Antimicrob Chemother; 2006 May; 57(5):1009-10. PubMed ID: 16524892
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir.
    Bottecchia M; Madejón A; Sheldon J; García-Samaniego J; Barreiro P; Soriano V
    J Antimicrob Chemother; 2008 Sep; 62(3):626-7. PubMed ID: 18467302
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R; Altindiş M; Gülamber G; Demirtürk N; Akcan Y; Demirdal T
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
    Gallego A; Sheldon J; García-Samaniego J; Margall N; Romero M; Hornillos P; Soriano V; Enrĺquez J
    J Viral Hepat; 2008 May; 15(5):392-8. PubMed ID: 18221300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral treatment of chronic hepatitis B with adefovir dipivoxil].
    Minami M; Okanoue T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():336-9. PubMed ID: 15453341
    [No Abstract]   [Full Text] [Related]  

  • 9. Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina.
    Cuestas ML; Rivero CW; Minassian ML; Castillo AI; Gentile EA; Trinks J; León L; Daleoso G; Frider B; Lezama C; Galoppo M; Giacove G; Mathet VL; Oubiña JR
    Antiviral Res; 2010 Jul; 87(1):74-7. PubMed ID: 20403388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B.
    Akman SA; Kose S; Halicioglu O
    Int J Infect Dis; 2010 Mar; 14(3):e236-9. PubMed ID: 19665408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.
    Hu Y; Zhang WL; Xie SL; Zhao Y; Hu JL; Cai XF; Lai GQ; Huang AL
    Genet Mol Res; 2012 Jan; 11(1):53-60. PubMed ID: 22290465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome.
    Amini-Bavil-Olyaee S; Herbers U; Mohebbi SR; Sabahi F; Zali MR; Luedde T; Trautwein C; Tacke F
    J Hepatol; 2009 Oct; 51(4):647-54. PubMed ID: 19586679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B.
    Liu LJ; Wang JH; Du SC; Tian JH; Yang RF; Wei L
    J Viral Hepat; 2010 Mar; 17 Suppl 1():66-72. PubMed ID: 20586936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir for lamivudine resistant HBV: more than meets the eye.
    Di Marco V; Craxì A
    J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.
    Marcellin P; Asselah T
    J Hepatol; 2005 Dec; 43(6):920-3. PubMed ID: 16246449
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
    Leemans WF; Janssen HL; Niesters HG; de Man RA
    J Viral Hepat; 2008 Feb; 15(2):108-14. PubMed ID: 18184193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.
    Yatsuji H; Suzuki F; Sezaki H; Akuta N; Suzuki Y; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Watahiki S; Iwasaki S; Kobayashi M; Kumada H
    J Hepatol; 2008 Jun; 48(6):923-31. PubMed ID: 18433925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.